Tioguanine, LDTA may be considered in IBD patients intolerant to conventional thiopurines
Both tioguanine and low‐dose thiopurines combined with allopurinol (LDTA) may be safely used in the treatment of inflammatory bowel disease (IBD) patients who have failed conventional thiopurines due to intolerance, a study has found.
Tioguanine, LDTA may be considered in IBD patients intolerant to conventional thiopurines
21 May 2020
